RecruitingNot ApplicableNCT05773144

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer


Sponsor

AdventHealth Translational Research Institute

Enrollment

219 participants

Start Date

Jun 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying how aerobic exercise — such as walking, cycling, or swimming — affects cancer treatment outcomes and quality of life in people with stage II or III colon cancer who are about to start chemotherapy after surgery. The exercise program is personalized and gradually increased over time. **You may be eligible if...** - You are 18 or older with confirmed stage II or III colon cancer - You have had surgery to remove the cancer and are planning to start chemotherapy - You currently exercise less than 60 minutes per week at moderate or vigorous intensity - You are physically able to walk 400 meters and are cleared to exercise - You can read and speak English **You may NOT be eligible if...** - You exercise more than 60 minutes per week already at moderate intensity - You have a major surgery planned during the study period - You have significant physical limitations that prevent safe exercise Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAerobic exercise

Moderate- to vigorous-intensity aerobic exercise

BEHAVIORALProgressive stretching

Static stretching of eight major muscle groups


Locations(3)

Kaiser Permanente Northern California

Oakland, California, United States

AdventHealth

Orlando, Florida, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05773144


Related Trials